Thomas L. Rothstein

Thomas L. Rothstein

Auto-generated profile, based on publicly available information

Thomas L. Rothstein

Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research, Manhasset, NY, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DGDaniel O. Griffin
Daniel O. Griffin
NHNichol E. Holodick
Nichol E. Holodick
TRThomas L. Rothstein
Thomas L. Rothstein
B1 cells differ in many ways from conventional B cells, most prominently in the production of natural immunoglobulin, which is vitally important for protection against pathogens. B1 cells have also been implicated in the pathogenesis of autoimmune dyscrasias and malignant diseases. It has been impossible to accurately study B1 cells during health and illness because the nature of human B1 cells has not been successfully defined. This has produced controversy regarding the existence of human B1 cells. Here, we determined the phenotype of human B1 cells by testing sort-purified B cell fractions for three fundamental B1 cell functions based on mouse studies: spontaneous IgM secretion, efficient T cell stimulation, and tonic intracellular signaling. We found that a small population of CD20+CD27+CD43+ cells present in both umbilical cord and adult peripheral blood fulfilled these criteria and expressed a skewed B cell receptor repertoire. These B cells express little or no surface CD69 and CD70, both of which are markedly up-regulated after activation of CD20+CD27−CD43− (naive) and CD20+CD27+CD43− (memory) B cells. This work identifies human B1 cells as CD20+CD27+CD43+CD70−. We determined that the proportion of B1 cells declines with age, which may contribute to disease susceptibility. Identification of human B1 cells provides a foundation for future studies on the nature and role of these cells in human disease.

27 August 2007 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
XZXuemei Zhong
Xuemei Zhong
JTJoseph R. Tumang
Joseph R. Tumang
WGWenda Gao
Wenda Gao
CBChunyan Bai
Chunyan Bai
TRThomas L. Rothstein
Thomas L. Rothstein
B1 B cells are the major source of natural antibody that is essential for innate immunity. The B1 repertoire is skewed toward production of phosphatidylcholine (PtC)‐binding VH11 and VH12 immunoglobulin that plays a key role in immune defense against bacterial infection. Programmed death‐ligand 2 (PD‐L2) is a ligand for the immunosuppressive receptor programmed death‐1 (PD‐1). It has been reported that expression of PD‐L2 is restricted to dendritic cells and macrophages in mice. Here we show that 50–70% of resting peritoneal B1 cells express PD‐L2, which is not present or inducible on conventional B2 B cells or PD‐L2– B1 cells. Although PD‐L2+ and PD‐L2– B1 cells are similar in proliferative responses and spontaneous immunoglobulin secretion, PD‐L2+ B1 cells are highly enriched for expression of VH11 and VH12 genes and encompass the bulk of PtC‐binding B1 cells. These findings extend the range of known PD‐L2 expression to B cells and show that B1 cells identified by this marker express a specific repertoire associated with anti‐bacterial immunity.

21 May 2013 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TRThomas L. Rothstein
Thomas L. Rothstein
DGDaniel O. Griffin
Daniel O. Griffin
NHNichol E. Holodick
Nichol E. Holodick
TQTam D. Quach
Tam D. Quach
HKHiroaki Kaku
Hiroaki Kaku

21 November 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
DGDaniel O. Griffin
Daniel O. Griffin
TRThomas L. Rothstein
Thomas L. Rothstein
A primary function of B lymphocytes is immunoglobulin production; however, the therapeutic benefit of B cell depletion in autoimmune diseases previously thought to be T cell mediated suggests that some B cells fulfill other roles in autoimmunity. We examined the recently identified human B1 cell population for T cell stimulatory activity. We found two kinds of B1 cells that are distinguished by multiple surface markers and distinct transcriptomic profiles. In both umbilical cord and adult peripheral blood, a CD11b+ subset constitutes ∼1 out of every 8–10 B1 cells, whereas a CD11b− subset constitutes the remaining B1 cells. These B1 cell populations differ functionally. CD11b− B1 cells spontaneously secrete much more IgM than CD11b+ B1 cells. In contrast, CD11b+ B1 cells express more CD86, and more efficiently stimulate allogeneic CD4+ T cell expansion, than CD11b− B1 cells. The frequency of these CD11b+ B1 cells is markedly elevated in lupus patients. CD11b+ B1 cells in lupus patients express more CD86 and have increased T cell–stimulating activity in disease. This work distinguishes a novel, T cell–interacting B1 cell population whose abundance and activity may be a reflection of, and a therapeutic target in, autoimmune disease.

27 August 2007 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
XZXuemei Zhong
Xuemei Zhong
WGWenda Gao
Wenda Gao
Nicolas DegauqueNicolas Degauque
Nicolas Degauque
CBChunyan Bai
Chunyan Bai
YLYan Lu
Yan Lu
TRThomas L. Rothstein
Thomas L. Rothstein
Regulatory T (Treg) cells are indispensable for maintaining peripheral tolerance, whereas T helper (Th)1 and Th17 cells induce inflammation and tissue destruction. Using Foxp3‐GFP knock‐in mice, we report a novel regulatory role for B cell subsets in influencing the differentiation of Treg versus Th1/Th17 cells. Peritoneal B1 cells strongly promoted T cell proliferation and cytokine secretion when presenting nominal or allogeneic antigens, as compared to conventional follicular B (B2) cells. However, peritoneal B1 cells largely failed to convert naive Foxp3–CD4+ T cells into Foxp3+ Treg cells in the presence of TGF‐β and IL‐2, in marked contrast to conventional B2 cells, which excelled in Treg conversion. Interestingly, under the same Treg conversion conditions, peritoneal B1 cells preferentially promoted Th1 and Th17 cell differentiation. Blockade of CD86 but not CD80 costimulation markedly enhanced Treg cell induction by B1 cells. Thus, B cell antigen presentation function is inversely correlated with de novo Treg cell induction for these B cell subsets. Our findings suggest that B1 and B2 cell subsets play distinct roles in immune regulation by promoting reciprocal differentiation of T cell lineages.

1 February 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TQTâm D. Quách
Tâm D. Quách
NRNely Rodríguez-Zhurbenko
Nely Rodríguez-Zhurbenko
THThomas J. Hopkins
Thomas J. Hopkins
XGXiaoti Guo
Xiaoti Guo
AHAna María Hernández
Ana María Hernández
TRThomas L. Rothstein
Thomas L. Rothstein
Human Ab-secreting cell (ASC) populations in circulation are not well studied. In addition to B-1 (CD20+CD27+CD38lo/intCD43+) cell and conventional plasmablast (PB) (CD20-CD27hiCD38hi) cell populations, in this study, we identified a novel B cell population termed 20+38hi B cells (CD20+CD27hiCD38hi) that spontaneously secretes Ab. At steady-state, 20+38hi B cells are distinct from PBs on the basis of CD20 expression, amount of Ab production, frequency of mutation, and diversity of BCR repertoire. However, cytokine treatment of 20+38hi B cells induces loss of CD20 and acquisition of CD138, suggesting that 20+38hi B cells are precursors to PBs or pre-PBs. We then evaluated similarities and differences among CD20+CD27+CD38lo/intCD43+ B-1 cells, CD20+CD27hiCD38hi 20+38hi B cells, CD20−CD27hiCD38hi PBs, and CD20+CD27+CD38lo/intCD43− memory B cells. We found that B-1 cells differ from 20+38hi B cells and PBs in a number of ways, including Ag expression, morphological appearance, transcriptional profiling, Ab skewing, Ab repertoire, and secretory response to stimulation. In terms of gene expression, B-1 cells align more closely with memory B cells than with 20+38hi B cells or PBs, but differ in that memory B cells do not express Ab secretion-related genes. We found that B-1 cell Abs use Vh4-34, which is often associated with autoreactivity, 3- to 6-fold more often than other B cell populations. Along with selective production of IgM anti–phosphoryl choline, these data suggest that human B-1 cells might be preferentially selected for autoreactivity/natural specificity. In summary, our results indicate that human healthy adult peripheral blood at steady-state consists of three distinct ASC populations.